An enzyme immunoassay (EIA; Gonozyme, Abbott Laboratories) for the antigenic detection of Neisseria gonorrhoeae in endocervical or urethral specimens was evaluated. EIA results were compared with results of conventional culture tests for N. gonorrhoeae. Specimens from 208 males (113 culture positive) and 252 females (72 culture positive) were tested. The sensitivity and specificity of EIA for specimens from males were 97.3 and 95.8%, respectively. The sensitivity and specificity of EIA for specimens from females were 79.2 and 87.2%, respectively.
reported in Erie County, N.Y., in 1982. As calculated from the 1980 census figure of 1,015,472 Erie County residents, the incidence of gonorrhea in Erie County was 396 per 100,000. The number of reported cases in Erie County has remained essentially constant since 1979.
Efforts to control the spread of gonorrhea include bacteriological screening of asymptomatic females and attempts to identify and treat sexual contacts of individuals with gonorrhea. Unfortunately, these efforts are hampered by the limitations of current laboratory methods for confirming the diagnosis of gonorrhea. Isolation of Neisseria spp. from clinical specimens and subsequent identification of the species of these isolates by biochemical and growth characteristics requires at least 2 days. This can be reduced to 24 h if coagglutination or fluorescent-antibody tests are used for the definitive identification of Neisseria gonorrhoeae (8, 14) . Regardless of the method used to identify Neisseria isolates by species, the sensitivity of a single endocervical culture for diagnosing gonorrhea in females appears to be less than 90% (2, 13, 15) . Clearly, a rapid, sensitive, and specific technique for detecting N. gonorrhoeae in clinical specimens would greatly assist public health efforts to control the spread of gonorrhea.
An enzyme immunoassay (EIA; Gonozyme, Abbott Laboratories, North Chicago, Ill.) for detecting antigen(s) of N. gonorrhoeae in urethral (males) or endocervical (females) swab specimens was recently introduced. The product is designed to evaluate clinical specimens for the presence of N. gonorrhoeae within 2 h. Our experience with this EIA is presented in this report. asymptomatic females were collected exclusively at the Sexually Transmitted Disease Clinic. Urethral (male) or endocervical (females) specimens were taken in duplicate from each patient on two separate swabs. The first swab was used for Gram stain, culture, or both; the second swab was used for the EIA.
MATERIALS
Bacteriological culture. Swab specimens were promptly streaked on Martin Lewis or modified Thayer-Martin agar plates at the site of specimen collection, and the plates were transported to the laboratory. The plates were incubated at 36°C in an atmosphere of 95% air and 5% CO2. Cultures were examined daily for 4 days. Suspect colonies were Gram stained and tested for the presence of cytochrome oxidase. Gram-negative diplococci that produced cytochrome oxidase were confirmed as N. gonorrhoeae by their capability to dissimilate dextrose, their failure to dissimilate maltose and sucrose, and their lack of growth at room temperature on chocolate agar (12, 18) .
EIA specimen processing and assay procedure. Immediately after swab specimens for the EIA were secured, they were placed into 100 jil of a specimen storage reagent (Abbott Laboratories) and refrigerated (2 to 8°C) for up to 5 days before testing. Before being tested, swabs were removed from specimen storage reagent and immersed in 1.0 ml of specimen dilution buffer (Abbott Laboratories) for 2 TP (3.5%) and 10 of 157 TN (6.4%) specimens had absorbances in this range.
The reproducibility in the EIA procedure was determined by testing specimens from the first 188 patients in duplicate and calculating the standard deviation for a single EIA determination (6) . For analysis, specimens were divided into two groups, those with mean absorbances of .0.50 (153 paired specimens) and those with absorbances between 0.51 and 1.999 (35 paired specimens). The standard deviations for a single EIA determination were 0.013 and 0.069 for the .0.5 and 0.51 to 1.999 groups, respectively.
DISCUSSION
The sensitivity (97.3%) and specificity (95.8%) of the EIA for male specimens would suggest this method as a suitable alternative to culture for establishing definitive evidence of gonorrhea. In two of the four males with FP EIAs, intracellular and extracellular gram-negative diplococci were seen in urethral exudates. Thus, the adjusted number of FP EIAs would be two since two of the four specimens fitting our definition of FP most likely represented problems associated with recovery of gonococci in culture rather than errors of the EIA. If these two specimens are considered TP rather than FP, the sensitivity and specificity of the EIA become 97.4 and 97.8%, respectively.
The sensitivity and specificity of the EIA for specimens from females were 79.2 and 87.2%, respectively. Chart review of 18 of the 23 females (charts for 5 females were unavailable) whose specimens yielded FP EIA results revealed that at the time of specimen collection, 3 patients were taking antibiotics known to inhibit growth of N. gonorrhoeae and 2 other patients were being evaluated for efficacy of treatment for a recent N. gonorrhoeae infection. Presumably, tests of cure patients could harbor breakdown For 52 men with symptoms of urethritis, Aardoom et al. (1) reported a sensitivity and specificity of 100% with the EIA procedure. For specimens from males, the sensitivity and specificity that we attained with the EIA were similar to those reported by Aardoom et al. In the same investigation, Aardoom et al. reported 86.7% sensitivity and 89.7% specificity for 54 female contacts of individuals suspected of having gonorrhea and 91.7% sensitivity and 96.7% specificity for 102 female prostitutes who regularly attended a clinic for sexually transmitted diseases. The specificity of EIA which we obtained with female specimens was similar to that obtained with the gonorrhea contact group of Aardoom et al. but was lower than that seen in the prostitutes. The sensitivity of EIA that we obtained with female specimens was lower than that obtained in either of the groups of Aardoom et al. for reasons that are not entirely clear.
The low sensitivity (79.2%) of the EIA for endocervical specimens may be due to a subpopulation of females with relatively few recoverable gonococci (9) . Clearly, the number of gonococci required for detection by culture (theoretically 1 viable organism) is less than the number required for detection by the EIA. Thus, specimens from individuals with sufficient numbers of gonococci for positive culture but insufficient for a positive EIA would yield FN EIA results. The method for specimen collection may have contributed to the high number of FN EIAs since two swabs, the first for culture and the second for the EIA, were taken from each patient. It is probable that the second swab would contain fewer gonococci than the first and would therefore be less likely to give a positive EIA result.
The high sensitivity of EIA for urethral specimens from symptomatic males suggests that the subpopulation of males with numbers of recoverable gonococci intermediate between that required for positive culture and that required for positive EIA either is very small or was excluded from the study because only symptomatic males were tested.
Another possible explanation for the substantial difference in the sensitivity of the EIA for specimens from males and females is the competition by antigen(s) (microorganisms other than N. gonorrhoeae) in the female genitourinary tract. According to EIA methodology, a suspension prepared from the specimen of the patient is incubated with a treated bead; gonococcal antigens, if present in the suspension, adsorb onto the bead. The bead, with adsorbed materials, is subsequently incubated with anti-N. gonorrhoeae rabbit serum. If nongonococcal antigens adsorb onto the bead, they may compete with gonococci for binding sites on the treated bead, thus inhibiting adsorption of gonococcal antigens. If the anti-N. gonorrhoeae rabbit serum does not recognize these adsorbed nongonococcal antigens, the resultant EIA will be negative, despite the presence of gonococcal antigens in the original suspension.
FP EIA results may be due either to the inability of organisms present in the specimen to grow on culture or to immunological recognition of antigen(s) from other organisms that cross-react with antigen(s) of N. gonorrhoeae. N. gonorrhoeae is a fastidious organism, and viability may be lost because of improper specimen handling (16, 17) . Similarly, vancomycin, which is present in Martin-Lewis and Thayer-Martin agars, inhibits growth of vancomycin-sensitive strains of N. gonorrhoeae (11) . The high positive predictive value of the EIA for males (96.5%) in contrast to that for females (71.3%), provides circumstantial evidence that improper specimen handling did not contribute significantly to FP EIA results. If improper specimen handling was a significant cause of FP EIA, males and females might be expected to have a similar proportion of FP EIA results since specimens from males and females were handled similarly. The role of growth inhibition by vancomycin in the culture media is more difficult to ascertain. If the incidence of these susceptible strains is the same in infections of males and females, then we could conclude that susceptible strains are rare because very few FP results were obtained with specimens from males. This reasoning is impaired by the choice of both symptomatic and asymptomatic females, compared with symptomatic males only, for study since it is well documented that asymptomatic infections in males are frequently due to strains that require arginine, hypoxanthine, and uracil (AHU strains) and that these AHU strains are highly susceptible to vancomycin (4, 7, 10, 11). Therefore, the role of inhibition of N. gonorrhoeae by vancomycin as a cause of FP EIA results is difficult to determine.
Lack of immunological specificity is the most reasonable explanation for the low positive predictive value of the EIA for specimens from females. Two observations support this view. First, the positive predictive value of the EIA was substantially higher for males (96.5%) than for females (71.3%); this suggests that certain antigenic determinants recognized by the EIA are present in specimens from females only. Surely the quantity and heterogeneity of the female genitourinary microbiota provides a far greater challenge to the specificity of immunological reagents than the comparatively sparse microbiota of the male urethra. Second, the photometric absorbance of a large proportion of FP female specimens was substantially lower than the absorbance of TP specimens. This suggests that the anti-N. gonorrhoeae rabbit serum binds weakly to nongonococcal antigens or to gonococcal antigens that cross-react with antigens of other microorganisms. The sensitivity and specificity of the assay for females might therefore be improved by carefully evaluating the antisera to determine and identify these antigens.
If the sensitivity and specificity of EIA for detection of N. gonorrhoeae in females can be improved, this assay could have a major impact on public health efforts to control the spread of gonorrhea. At present, however, one potential deterrent to using the EIA to identify N. gonorrhoeae is that organisms would not be available for assessing ,-lactamase production.
